Catalyst Wire Dossier Catalyst Wire Dossier

COL-1077 Lidocaine Bioadhesive Gel, 10%

lidocaine bioadhesive gel · Juniper Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COL-1077 Lidocaine Bioadhesive Gel, 10%, covering 2016-07-13 to 2016-07-13. Get the full timeline:

Most recent: Clinical Trial Update: COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy [Phase 2]

See pricing